Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Pozycja w akcjach #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Cena akcji
$0.04057595
Ostatnia synchronizacja: 2024-08-05
Kapitalizacja rynkowa
$863.62K
Zmiana (1 dzień)
0.31%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel AegirBio AB (publ) (AEGIR)

Kategoria

Historia stopy dywidendy dla AegirBio AB (publ) (AEGIR)
Stopa dywidendy (TTM) dla AegirBio AB (publ) (symbol akcji: AEGIR) na dzień 2022-12-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla AegirBio AB (publ) (AEGIR) od 2019 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji